Literature DB >> 6839545

The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment.

J C Roder, R F Todd, P Rubin, T Haliotis, S L Helfand, J Werkmeister, H F Pross, L A Boxer, S F Schlossman, A S Fauci.   

Abstract

Lymphocytes from six Chediak-Higashi (CH) patients were markedly depressed in their ability to lyse tumour cell targets in both 51Cr release and single cell cytotoxicity assays. The frequency of lymphocytes bearing the OKM1 marker and the frequency of T3+, T4+, T8+, Ia+, Mo1+, Mo2+ and B1+ cells was normal among sheep erythrocyte rosetting (E+) and non-rosetting (E-) peripheral blood leucocytes analysed by flow cytofluorography. Cells expressing the NK shared markers, OKM1, mac-1, FcR, and the characteristic large granular lymphocyte (LGL) morphology of NK cells were also present in normal numbers in the highly enriched NK fraction separated on Percoll density gradients. This fraction did not contain detectable numbers of cells expressing the Mo2 marker of human monocytes. Therefore most of the cells stained by monoclonal OKM1 and mac-1 in this fraction are likely NK cells, rather than monocytes, and we conclude that the size of the NK pool in CH patients is probably normal. The capacity of CH lymphocytes to recognize and bind to tumour cells was also normal as was the subsequent burst of oxygen intermediates produced by the NK cells in a chemiluminenscence assay. We have shown elsewhere that O2- generation is directly involved in activating subsequent steps in the NK cytolytic pathway. These results suggest that NK cells in CH patients are present in normal frequency but are blocked at some post-recognition, post-activation step in the cytolytic pathway subsequent to the burst of oxygen intermediates but preceding the lethal hit.

Entities:  

Mesh:

Year:  1983        PMID: 6839545      PMCID: PMC1536889     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Role of microtubules in granulocyte adherence.

Authors:  L A Boxer; J M Allen; A M Watanabe; H R Besch; R L Baehner
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

2.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

Review 3.  Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.

Authors:  E Saksela; T Timonen; A Ranki; P Häyry
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

4.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides.

Authors:  J C Roder; M Klein
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.

Authors:  R A Clark; H R Kimball
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

8.  Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells.

Authors:  J C Roder; S L Helfand; J Werkmeister; R McGarry; T J Beaumont; A Duwe
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

9.  Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.

Authors:  M Klein; J Roder; T Haliotis; S Korec; J R Jett; R B Herberman; P Katz; A S Fauci
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

10.  Chédiak-Higashi gene in humans I. Impairment of natural-killer function.

Authors:  T Haliotis; J Roder; M Klein; J Ortaldo; A S Fauci; R B Herberman
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  1 in total

Review 1.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.